Cancer biomarkers : section A of Disease markers

Cancer Biomark · ISSN (print) 1574-0153 · 29 papers in corpus
2024
doi:10.3233/cbm-230261 ·PMID:37955081

BackgroundLong-chain noncoding RNA (lncRNA), LINC01569, is important for regulating the extracellular matrix, which affects cell migration. However, its involvement in the occurrence and development of triple-negative breast cancer (TNBC) r…

2023
doi:10.3233/cbm-230103 ·PMID:37599524

BackgroundNumerous evidence have suggested the vital role of lncRNAs in human tumorigenesis. And lncRNA APAP1-AS1 has been proved to act as an oncogene.ObjectiveNevertheless, the molecular process underlying ARAP1-AS1 for the lymphoma progr…

2022
doi:10.3233/cbm-220018 ·PMID:36245369

MethodsTalin-1 protein was demonstrated as a potential prognostic marker in renal cell carcinoma (RCC) using bioinformatics analysis. We, therefore, examined the protein expression levels and prognostic significance of Talin-1 with a clinic…

2022
doi:10.3233/cbm-210435 ·PMID:35634847

BackgroundOvarian clear cell carcinomas (OCCCs) have been recurrent and refractory among the present treatments, so novel therapeutics are urgently needed.ObjectiveThe present study accumulates the proof of concept to examine the feasibilit…

2020
doi:10.3233/cbm-190988 ·PMID:32083570

BackgroundThe majority of ovarian cancer cases are diagnosed at an advanced stage with poor prognosis. This study evaluates autoantibodies against tumor antigens to identify candidate biomarkers for early detection of ovarian cancer in wome…

article 2018
doi:10.3233/cbm-181836 ·PMID:30594917

BACKGROUND: Endometrioid ovarian carcinoma and clear cell ovarian carcinoma are both classified as endometriosis-associated ovarian cancer (EAOC). Despite the high rates of recurrence and mortality of EAOC, no prognostic biomarkers have bee…

2018
doi:10.3233/cbm-170846 ·PMID:29689706

BackgroundPeople with biomarkers above cut-off values normally have higher risk to develop pre-malignancies and malignancies.ObjectiveHere we investigate if serological TK1 protein (STK1p), AFP, CEA and PSA below cut-off values predict deve…

2017
doi:10.3233/cbm-170305 ·PMID:29036787

BackgroundEarly detection and differentiation diagnosis of a pelvic mass (PM) is crucial in improving the prognosis of patients with epithelial ovarian cancer (EOC). C-C motif chemokine ligand 18 (CCL18) was reported as a chemokine-mediated…

article 2017
doi:10.3233/cbm-170720 ·PMID:29226858

OBJECTIVE: This study aims to investigate the clinical significance of serum Smac, HE4 and CA125 alone or combined for detecting endometriosis-associated ovarian cancer (EAOC). METHODS: The level of serum Smac, HE4 and CA125 in 40 healthy c…

2017
doi:10.3233/cbm-160505 ·PMID:28282801

Here one concurrent case of a patient with both thyroid and breast cancers was discussed with a comprehensive literature review. On March 21, 2016, a 42-year-old female patient was admitted into our hospital because of right neck mass and l…

2015
doi:10.3233/cbm-150534 ·PMID:26444485

BackgroundGastric cancer is the fourth most frequent cancer and the second cause of cancer-related deaths worldwide. China has a high incidence of gastric cancer. Inflammation is a critical component of tumor progression. It has been widely…

article 2015
doi:10.3233/cbm-150484 ·PMID:25835178

OBJECTIVE: The purpose of this study was to investigate cyst fluid levels of total iron, heme iron and free iron in benign endometriotic cysts and endometriosis-associated ovarian cancer (EAOC) and to demonstrate the significance of these b…

2015
doi:10.3233/cbm-150457 ·PMID:25586095

BackgroundSerous epithelial ovarian cancer is the most common variety of ovarian cancer and is currently diagnosed using serum CA-125 levels. HMGA1 a small 10.6-12 kDa protein, has been implicated as a potentially important tumor biomarker …

2015
doi:10.3233/cbm-150485 ·PMID:25835179

BackgroundAmong various polymorphic variants of TP53 gene, codon 72 polymorphism (Arg72Pro) has been found to be associated with cancer susceptibility, but only few studies have investigated their effect on thyroid cancer risk.ObjectiveA ca…

2014
doi:10.3233/cbm-140415 ·PMID:25171477

BackgroundThe expressions of leptin and its receptor (ObR) have been observed in human endometrial cancer (EC) cells, and leptin can promote the proliferation of EC cells. However, the correlation between leptin and ObR expressions in EC an…

2014
doi:10.3233/cbm-130326 ·PMID:24878818

Determining the primary site of uterine adenocarcinoma (ADC) may be problematic, especially with small specimens. This is particularly important in light of the increase of endocervical and endometrial adenocarcinoma and the decrease in inc…

2014
doi:10.3233/cbm-130375 ·PMID:24643043

The Tn antigen is a tumor-associated carbohydrate antigen that is not normally expressed in peripheral tissues or blood cells. Expression of this antigen, which is found in a majority of human carcinomas of all types, arises from a blockage…

2013
doi:10.3233/cbm-130348 ·PMID:24240584

BackgroundVascular endothelial growth factor (VEGF) gene is an important angiogenesis regulator related to cancer development and progression. We evaluated the association between -2578 C/A (rs699947) VEGF polymorphism and PCa in Mexican su…

2012
doi:10.3233/cbm-120291 ·PMID:23248185

Cancer statistics show significant diagnosis numbers amongst men and women worldwide, where breast cancer is by far the most frequently diagnosed cancer in women. Multiple mechanisms and molecules have been shown to occupy major roles in ca…

2012
doi:10.3233/cbm-130304 ·PMID:23568007

BackgroundCarbohydrate antigen 125 (CA-125) is a glycoprotein produced by epithelial and mesothelial cells. Serum CA-125 can be elevated in many benign and malignant conditions in which these tissues are involved.MethodsWe measured serum CA…

2011
doi:10.3233/cbm-2012-0255 ·PMID:22820082

ObjectiveThe study sought to identify whether a relationship exists between serum myeloperoxidase (MPO) and free iron with stages of ovarian cancer.MethodsSerum and tissue samples were collected from women with stages I through IV ovarian c…

2010
doi:10.3233/cbm-2011-0219 ·PMID:22045351

In the clinical setting the vast majority of positron emission tomography (PET) procedures use the glucose analogue F-18 fluorodeoxyglucose (FDG) to visualize the increased glucose consumption of malignant lesions. Co-registered PET/CT has …

2010
doi:10.3233/cbm-2011-0167 ·PMID:22112481

Pregnancy, breastfeeding, and oral contraceptive pill use interrupt menstrual cycles and reduce endometrial and ovarian cancer risk. This suggests the importance of turnover within Mullerian tissues, where the accumulation of mutations in p…

2010
doi:10.3233/cbm-2011-0212 ·PMID:22045356

Epithelial ovarian cancer (EOC) remains the most lethal gynecological malignancy despite several decades of progress in diagnosis and treatment. Taking advantage of the robust development of discovery and utility of prognostic biomarkers, c…

2010
doi:10.3233/cbm-2011-0210 ·PMID:22045352

The early detection of ovarian cancer represents a clinical objective with an enormous potential for a meaningful improvement in our ability to treat and cure afflicted patients. The magnitude of this potential is matched by the challenges …